Molecular and Clinical Oncology

Molecular and Clinical Oncology is a peer-reviewed scientific research journal dedicated to publishing the latest in cancer research.

[Spandidos Publications @SpandidosP]

The overall trend in Impact Factors for Spandidos Publications Journals featured in JCR over the course of the last 11 years is shown in the attached graphic.

[Spandidos Publications @SpandidosP]

The new Impact Factors for the Spandidos Publications journals that are indexed in JCR are shown in tabulated form in the attached graphic.

[Spandidos Publications @SpandidosP]

Following the release of Journal Citation Reports 2022 (published by Clarivate), we are pleased to announce some significant increases in the Impact Factors (IFs) for our Journals. All listed Journals have seen their IFs increase. More information to come in the following thread!

[Spandidos Publications @SpandidosP]

We are pleased to announce that all of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2021'. Here is a summary all the updated information at a glance in a graphic:

[Spandidos Publications @SpandidosP]

Molecular and Clinical Oncology has moved into the Third Quartile (Q3) in Citescore 2021: latest CiteScore, 1.6; in Quartile Q3 [cf. 0.8, Q4 in 2020].

[Spandidos Publications @SpandidosP]

We are pleased to announce that all of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2021'. Specific details on each of the journals are to follow:

[Spandidos Publications @SpandidosP]

The overall trend in Impact Factors for Spandidos Publications Journals featured in JCR over the course of the last decade is shown in the attached graphic.

[Spandidos Publications @SpandidosP]

The new Impact Factors for the Spandidos Publications journals that are indexed in JCR are shown in tabulated form in the attached graphic.

[Spandidos Publications @SpandidosP]

Following the release of Journal Citation Reports 2021 (published by Clarivate), we are pleased to announce some significant increases in the Impact Factors for several of our Journals. More information to come in the following thread.

[Spandidos Publications @SpandidosP]

We would like to thank all our authors, reviewers, Editorial Boards and Academies, and office staff in Athens and London for their contributions to these achievements.

[Spandidos Publications @SpandidosP]

Molecular Clinical Oncology (first year data): latest CiteScore, 0.8; Percentile, 21% (267/340); in Quartile Q4.

[Spandidos Publications @SpandidosP]

We are pleased to announce that the majority of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2020'. Specific details on each of the journals are to follow:

[Spandidos Publications @SpandidosP]

We would like to thank all our authors, reviewers, Editorial Boards and Academies, and office staff in Athens and London for their contributions to these achievements.

[Spandidos Publications @SpandidosP]

Please visit our website to browse recently published articles, learn about our services for English Language Editing, Formatting and Figure Preparation, and to submit your next manuscript.

We would like to thank you for your continued support.

[Spandidos Publications @SpandidosP]

The Scopus data were released this week, and we were delighted to see all our journals increase their impact (cite scores). In particular, @IjOncology (81%; 62/331 Oncology), @OncologyReports and @BiomedicalRepo1 are in the first quartiles in their respective categories.

[Spandidos Publications @SpandidosP]

Based on the same database, Spandidos Publications are ranked 13th in terms of the average number of citations per article in 2014-2016 (out of the top 30 publishers in the world by volume).

[Spandidos Publications @SpandidosP]

According to the latest information from the Scimago database (based on Scopus), Spandidos Publications are ranked 27th among publishers in terms of the number of articles published in 2017 (out of ~8,700 publishers).

[Spandidos Publications @SpandidosP]

A visual display of the trend of rising Impact factors for six of Spandidos Publications' portfolio of journals, covering the period 2010-2018 - and the same information shown in the form of a chart.

[Spandidos Publications @SpandidosP]

The latest in our series of podcasts: an interview with Dr George Pissas at the University of Athens on how the preconditioning of primary human renal epithelial cells in the absence of tryptophan may increase their survival under conditions of ER stress https://t.co/8JyYSDl4lB

[Spandidos Publications @SpandidosP]

Our latest podcast: Dr Monica Botelho at INSA, Instituto Nacional De Saúde Dr Ricardo Jorge, Porto, Portugal, discusses her work on the mechanistic role of estrogen-related molecules in the processes of Schistosoma haematobium-associated bladder cancer. https://t.co/Y9K6jdYKRl